Dr. Marco Marigliano is specialized in Pediatrics since 2009 at the University of Ancona. After his specialization he worked as a researcher at the Immunogenetics Division of the Department of Pediatrics of the Children's Hospital of Pittsburgh (USA) in the field of pancreatic beta-cell transplants in subjects affected by Type 1 Diabetes. Since 2012 he has collaborated with the Center Regional Pediatric Diabetology (CRDP) of Verona, where he carries out clinical and research activities in particular in the field of new technologies applied to Type 1 Diabetes (insulin pumps and continuous blood glucose sensors). In 2013 he obtained the II level Inter-University Master (Parma-Verona) in "Management of Diabetes and related metabolic disorders in developmental age" and in 2017 he obtained his PhD in Multimodal Imaging in Biomedicine at the University of Verona with a thesis entitled "Application of new technologies in the treatment of insulin dependent diabetes in children: analysis of the flow and metabolic fate of substrates in the postprandial phase". He is a member of the Italian Society of Pediatrics (SIP) and of the Italian Society of Pediatric Endocrinology and Diabetology (SIEDP) and of the related Diabetes Study Group. He contributed to the drafting of the Guidelines of the Society of Pediatric Endocrinology and Diabetology (SIEDP) on insulin therapy and the use of technology in patients with Type 1 Diabetes.
He has over 55 publications indexed on PubMed in the field of clinical research in Pediatrics on type 1 diabetes, type 2 diabetes, monogenic diabetes, nutrition, use of technology (automatic insulin release and glycemic monitoring) in patients with Type 1 diabetes , cardiovascular risk factors, epidemiology of T1D.
Modules running in the period selected: 0.
Click on the module to see the timetable and course details.
|Pediatric diabetes||Pathophysiology of Type 1 Diabetes in Pediatrics. Use of new technologies for the management of DT1.||Pediatrics|